Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Tuesday, April 23, 2024

Asian group asks Taiwan to recognize tobacco harm reduction as a...

National, May 20, 2020: An Asia-Pacific consumer advocacy group has supported the petition asking the Taiwanese government to recognize tobacco harm reduction as a...

PharmEasy Offers Flat Discount on All Medicine Orders

Mumbai, April 06, 2019: In the age we live in, everything arrives at our doorstep. Be it food, clothes, gadgets or books - it...

Biotechnology

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Pioneering Real World Study Reveals Successful Tele-ICU Collaboration for Remote Critical Care

BENGALURU, AUGUST 24,2023: In a recent publication that promises to reshape the landscape of healthcare accessibility, a research paper titled "A successful model of a Private-Public...

IT & Software Support

Appointments

Parexel International appoints Clare Grace as Chief Patient Officer

Newly-Created Role to reinforce focus on patients Appointment is a first for a top-tier CRO  India, January 08, 2021: Parexel, a leading provider of solutions...

Awards

Sepsivac® receives Covid-19 Pharma Excellence Award

Ahmedabad, August 26, 2020: Sepsivac®,the latest innovation Cadila Pharmaceutical recently received the prestigious Pharma Excellence Awardat the Emerging Dimensions in Pharma Excellence e-Summit organised...

Financial Results

Approvals

Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment

Can market in India and 104 other countries Has also received DCGI regulatory license for Indian market Licenses applicable for both API and...

Clinical Trails

.MP Baijayant “Jay” Panda Asks India to Embrace Modern Science in Support of Humane...

MP Baijayant "Jay" Panda Asks India to Embrace Modern Science in Support of Humane Society International's Campaign to End Animal Testing for Cosmetics

New Delhi, Delhi, India, Thursday, March 14, 2013 -- (Business Wire India) -- Member of Parliament Baijayant "Jay" Panda calls on the government to end animal testing for cosmetics in India - giving a boost to a campaign that is spreading around the world. Panda, an elected representative from Kendrapara, Odisha, wrote letters to the Ministers of Health and Family Welfare, Environment and Forests, and Consumer Affairs, supporting Humane Society International/India's call to end to cosmetic testing on animals as soon as possible.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Optimizing Optic Health: Your Comprehensive Guide to Glaucoma Mastery

Dr. K Harshitha, Cataract and Glaucoma Surgeon, Maxivision Eye Hospitals, Hyderabad Glaucoma, often known as the "silent thief of sight," is a group of eye...

ENTOD Pharmaceuticals Observes 38th National Eye Donation Fortnight Brighten Lives through Awareness

NEW DELHI,September  04 , 2023:  Entod Pharmaceuticals, a renowned pharmaceutical company in India, proudly announces a transformative event slated to run on the occasion...

Product News

Demand for immunity products to be sustained long-term say SIRIO

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19  New Delhi, May 11, 2020: SIRIO Europe (Ayanda) – the European headquarters of...

Media Partners

Spotlight

Investments

Packaging

Latest News

Your everyday habits could be mounting trouble for your heart

By Dr. Naveen Chandra-Consultant - Interventional Cardiology, Columbia Asia Hospital Whitefield  From a time when cardiac arrest was a rare phenomenon usually occurring due to...

Revolutionizing Cancer Treatment: The Synergy of Radiation Oncology and Immunotherapy

Dr. Vividha Dubey, MD Radiation Oncology, HCG hospitals, Bhavnagar Cancer has long been one of modern medicine's most powerful rivals, costing millions of lives worldwide. While substantial...

Dental Care

Hospital Management

Drug Discovery & Development

Suppliers

Technology

Cost-Effective, Reliable Performance is Easily Achieved with Alfa Laval’s New Optilobe...

Cost-Effective, Reliable Performance is Easily Achieved with Alfa Laval’s New Optilobe Rotary Lobe Pumps
New Delhi, August 07, 2019: Alfa Laval OptiLobe rotary lobe pumps are cost-effective, reliable and versatile alternatives for general applications requiring gentle product treatment...

Companies

Marketing

Our Partners

Machinery & Equipments